
HCW Biologics
HCW: Expert immunotherapy developer targeting chronic inflammation and senescent cell clearance.
- 33
- Company
- Miramar, FL, USUnited States
Founded with a mission to extend healthspan by addressing chronic inflammation, HCW Biologics is a clinical-stage company specializing in the development of innovative immunotherapies. The company leverages its expertise in immunology to create proprietary treatments aimed at modulating inflammasomes and clearing senescent cells. By targeting these underlying mechanisms, HCW Biologics seeks to combat inflammaging and improve overall health outcomes.
Notable figures associated with HCW Biologics include experienced immunologists and biotech investors who support its groundbreaking research. The company has achieved significant milestones, including advancing its therapeutic candidates into clinical trials. HCW Biologics' work has the potential to revolutionize treatments for age-related diseases, positioning it as a leader in the field of immunotherapy for inflammaging.
Similar Companies

Siwa Therapeutics

HI-Bio
hibio.com

Cambrian BioPharma
cambrianbio.com

InflammX Therapeutics
inflammx.com

Immvention Therapeutix

Inmagene Biopharmaceuticals
inmagenebio.com

Helocyte
helocyte.com

Inflammasome Therapeutics
inflam.com
ImmunityBio

IpiNovyx Bio

Equillium
equilliumbio.com

Immunis

Cleveland BioLabs

CytoAgents
cytoagents.com

Seneca Therapeutics

Therini Bio
therinibio.com

Inimmune
inimmune.com

Avenge Bio
avengebio.com
Orion BioScience

AgeX Therapeutics
Quick Facts
Who are HCW Biologics' competitors?
Companies similar to HCW Biologics include Siwa Therapeutics, HI-Bio, Cambrian BioPharma and InflammX Therapeutics.
When was HCW Biologics founded?
HCW Biologics was founded in 2018.
Where is HCW Biologics' headquarters located?
HCW Biologics' headquarters is located in Miramar, FL, US.
When was HCW Biologics' last funding round?
HCW Biologics' most recent funding round was for $1.6M (USD) in July 2026.
How much disclosed funding has HCW Biologics raised?
As of Jul 29, 2026, HCW Biologics has disclosed funding of $67.1M (USD). Undisclosed round amounts are excluded.
How many employees does HCW Biologics have?
HCW Biologics has 33 employees as of Feb 6, 2024.
Classification
- Industry
- Ownership
- Technology
- Geographic Exposure
- Customer
- Main Product
- Tags
- Also Known As
- HCW Biologics Inc.
- Headquarters
- 2929 North Commerce Parkway
- Miramar, FL, 33025
- US
- Ticker
- HCWB
- SEC CIK
- 0001828673
- EIN
- 82-5024477
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 2800Chemicals And Allied Products
- 2830Drugs
- 2834Pharmaceutical Preparations
- ISIC
- 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
- Industry
- —Biotechnology Companies
- —Health Care Companies
- —Medical Organizations
- —Pharmaceutical Companies
Show 14 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 620000Health Care and Social Assistance
- 325000Chemical Manufacturing
- 623000Nursing and Residential Care Facilities
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 4000Railroad Transportation
- 8000Health Services
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8040Offices And Clinics Of Other Health Practitioners
- 8730Research, Development, And Testing Services
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
- 8731Commercial Physical and Biological Research